Live from the NIH registry
Studies recruiting near Sunnyvale right now
Top 25 of 1,164 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Stanford University School of Medicine — Palo Alto, California (7.6 mi)
· Sponsor: University of Michigan
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Stanford Cancer Center — Stanford, California (8.2 mi)
· Sponsor: Syndax Pharmaceuticals
Decreasing Emergence Agitation With Personalized Music
Surgical Procedure, Unspecified
N/A
Interventional 100 participants sought
Stanford University — Stanford, California (8.2 mi)
· Sponsor: Stanford University
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
Stanford University: Stanford Children's Health — Redwood City, California (13.5 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
Drug Resistant Epilepsy, Epilepsy
Phase 1, Phase 2
Interventional 8 participants sought
Stanford University School of Medicine — Palo Alto, California (7.6 mi)
· Sponsor: NaviFUS Corporation
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
N/A
Interventional 808 participants sought
VA Palo Alto Health Care System, Palo Alto, CA — Palo Alto, California (7.6 mi)
· Sponsor: VA Office of Research and Development
Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML
Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 20 participants sought
Stanford University — Palo Alto, California (7.6 mi)
· Sponsor: Stanford University
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
NorCal Endocrinology and Internal Medicine — San Ramon, California (27.5 mi)
· Sponsor: Novo Nordisk A/S
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
150 — Palo Alto, California (7.6 mi)
· Sponsor: Corcept Therapeutics
SWIR Otoscopy Study
Otitis Media, Otitis Media Chronic
N/A
Interventional 100 participants sought
Stanford University — Palo Alto, California (7.6 mi)
· Sponsor: Stanford University
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Epithelioid Hemangioendothelioma (EHE)
Phase 2
Interventional 41 participants sought
Stanford University — Stanford, California (8.2 mi)
· Sponsor: Sarcoma Alliance for Research through Collaboration
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Stanford University Medical Center — Stanford, California (8.2 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Allergy & Asthma Consultants — Redwood City, California (13.5 mi)
· Sponsor: Celldex Therapeutics
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
Stanford Hospitals and Clinics — Stanford, California (8.2 mi)
· Sponsor: Cook Research Incorporated
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Stanford Hospital and Clinic — Stanford, California (8.2 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Lucile Packard Children's Hospital Stanford University — Palo Alto, California (7.6 mi)
· Sponsor: National Cancer Institute (NCI)
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Diabetes Mellitus, Type 2
N/A
Interventional 119,680 participants sought
Board of Trustees of the Leland Stanford Junior University — Stanford, California (8.2 mi)
· Sponsor: Stanford University
Prehabilitation and Rehabilitation in PAD
Peripheral Arterial Disease
N/A
Interventional 300 participants sought
VA Palo Alto Health Care System — Palo Alto, California (7.6 mi)
· Sponsor: Palo Alto Veterans Institute for Research
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Palo Alto Medical Foundation Research Center — Sunnyvale, California (1.2 mi)
· Sponsor: Hoffmann-La Roche
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Kaiser Permanente — Santa Clara, California (4.4 mi)
· Sponsor: Eli Lilly and Company
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Stanford Medicine Children's Health — Palo Alto, California (7.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
Local Institution - 0178 — Palo Alto, California (7.6 mi)
· Sponsor: Bristol-Myers Squibb
Mobile Technology to Measure Knee Health in Osteoarthritis
Osteoarthritis, Knee
N/A
Observational 47 participants sought
VA Palo Alto Health Care System, Palo Alto, CA — Palo Alto, California (7.6 mi)
· Sponsor: VA Office of Research and Development
Advancing Scalable Alcohol Brief Interventions in the ED: A Trial of Conversational AI With Digital Reinforcements
Alcohol Misuse
N/A
Interventional 750 participants sought
Stanford University Medical Center — Palo Alto, California (7.6 mi)
· Sponsor: Stanford University
A Study of Esomeprazole in Children With Autism
Autism, Autism Spectrum Disorder
Phase 2
Interventional 25 participants sought
Stanford University School of Medicine — Stanford, California (8.2 mi)
· Sponsor: Stanford University